EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Glioblastoma: An Update in Pathology, Molecular Mechanisms and Biomarkers

Zhong Lan iD, Xin Li, Xiaoqin Zhang iD

International Journal of Molecular Sciences · 06.03.2024 · 25 (5) · 3040

DOI: 10.3390/ijms25053040 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 06.03.2024. Verfasst von Zhong Lan und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, School of Medicine, South China University of Technology, Guangzhou 510006, China. Hauptthemen laut MEDLINE: Biomarkers, Tumor, Brain Neoplasms, Glioblastoma. Die Arbeit wurde bisher 141-mal zitiert (Crossref) und nennt 99 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glioblastoma multiforme (GBM) is the most common and malignant type of primary brain tumor in adults. Despite important advances in understanding the molecular pathogenesis and biology of this tumor in the past decade, the prognosis for GBM patients remains poor. GBM is characterized by aggressive biological behavior and high degrees of inter-tumor and intra-tumor heterogeneity. Increased understanding of the molecular and cellular heterogeneity of GBM may not only help more accurately define specific subgroups for precise diagnosis but also lay the groundwork for the successful implementation of targeted therapy. Herein, we systematically review the key achievements in the understanding of GBM molecular pathogenesis, mechanisms, and biomarkers in the past decade. We discuss the advances in the molecular pathology of GBM, including genetics, epigenetics, transcriptomics, and signaling pathways. We also review the molecular biomarkers that have potential clinical roles. Finally, new strategies, current challenges, and future directions for discovering new biomarkers and therapeutic targets for GBM will be discussed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Biomarkers, TumorBrain NeoplasmsGlioblastomaHumansEpigenesis, GeneticGene Expression Regulation, NeoplasticPrognosisSignal Transduction

Stichwörter der Autor:innen

biomarkersepigeneticsgeneticsglioblastomahistopathologymolecular pathologysignaling pathwaytranscriptomics

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Department of Pathology, School of Medicine, South China University of Technology, Guangzhou 510006, China.

ORCID-Profile: Zhong Lan, Xiaoqin Zhang

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Lan, Z., Li, X., & Zhang, X. (2024). Glioblastoma: An Update in Pathology, Molecular Mechanisms and Biomarkers. International Journal of Molecular Sciences, 25(5), 3040. https://doi.org/10.3390/ijms25053040

Vancouver

Lan Z, Li X, Zhang X. Glioblastoma: An Update in Pathology, Molecular Mechanisms and Biomarkers. International Journal of Molecular Sciences. 2024;25(5):3040. doi:10.3390/ijms25053040

BibTeX
@article{Lan2024,
  author = {Lan, Zhong and Li, Xin and Zhang, Xiaoqin},
  title = {Glioblastoma: An Update in Pathology, Molecular Mechanisms and Biomarkers},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  volume = {25},
  number = {5},
  pages = {3040},
  doi = {10.3390/ijms25053040}
}
Kostenlos starten →